Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,897
Total Claims
$1.2M
Drug Cost
237
Beneficiaries
$5,090
Cost/Patient
Risk Score Breakdown 18/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-55%
Opioid rate vs peers
1.7% vs 3.8% avg
+333%
Cost per patient vs peers
$5,090 vs $1,174 avg
+128%
Brand preference vs peers
20.2% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.7%
Opioid Rate
152
Opioid Claims
$1,970
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,791 claims · $1.0M
Generic: 7,074 claims · $201K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Lipase/Protease/Amylase | 215 | $183K |
| Icosapent Ethyl | 276 | $116K |
| Dulaglutide | 107 | $106K |
| Apixaban | 110 | $66K |
| Semaglutide | 54 | $60K |
| Denosumab | 29 | $50K |
| Linaclotide | 74 | $47K |
| Rivaroxaban | 47 | $31K |
| Empagliflozin | 20 | $28K |
| Dexlansoprazole | 98 | $27K |
| Lidocaine | 115 | $24K |
| Insulin Aspart | 29 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 39 | $18K |
| Tenofovir Alafenamide | 12 | $18K |
| Budesonide/Formoterol Fumarate | 37 | $15K |
Prescribing Profile
Patient Profile
75
Avg Age
60%
Female
1.45
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About